세계의 구강 수면무호흡증 기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Oral Sleep Apnea Devices Market is presumed to reach the market size of nearly USD 1603.39 Million by 2032 from USD 851.15 Million in 2023 with a CAGR of 7.29% under the study period 2024 - 2032.

Oral sleep apnea devices, or mandibular advancement devices (MADs) or dental appliances, are custom-fitted oral devices prescribed to treat obstructive sleep apnea (OSA) and snoring. These devices are worn during sleep to reposition the lower jaw and tongue forward, thus preventing airway collapse and improving airflow to alleviate symptoms of sleep-disordered breathing. For individuals experiencing mild to moderate OSA, oral sleep apnea devices offer a substitute for continuous positive airway pressure (CPAP) therapy.

MARKET DYNAMICS

The increasing prevalence of sleep apnea, a common sleep disorder featured by pauses in breathing during sleep, has led to growing awareness and diagnosis of the condition, driving demand for effective treatment options such as oral sleep apnea devices. These devices, including mandibular advancement devices (MADs) and tongue retaining devices (TRDs), work by adjusting the position of the jaw or tongue to maintain an open airway during sleep, lessening the severity of sleep apnea symptoms and enhancing overall sleep quality. Additionally, the rising preference for non-invasive and patient-friendly treatment alternatives to continuous positive airway pressure (CPAP) therapy, considered the benchmark treatment for sleep apnea, has fueled interest in oral sleep apnea devices among patients who find CPAP masks uncomfortable or cumbersome, driving market adoption. Moreover, advancements in dental technology, materials science, and 3D printing techniques have led to custom-fit and adjustable oral sleep apnea devices that offer improved comfort, durability, and efficacy, driving market innovation and differentiation.

Furthermore, the growing collaboration between sleep specialists, dentists, and manufacturers to raise awareness, improve diagnosis, and optimize treatment protocols for sleep apnea has contributed to market growth by expanding access to oral sleep apnea devices and promoting multidisciplinary approaches to sleep disorder management. Lastly, the impact of the COVID-19 pandemic on lifestyle changes, stress levels, and disrupted sleep patterns has heightened awareness of sleep health and the importance of addressing sleep-related issues, driving market demand for oral sleep apnea devices as part of comprehensive sleep disorder management strategies, further fuelling market expansion. However, concerns regarding device efficacy, patient compliance, and competition from alternative treatment options may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral sleep apnea devices. The growth and trends of oral sleep apnea devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the oral sleep apnea devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Diagnostic Devices (Actigraphs, Polysomnography (Psg) Device, Respiratory Polygraphs, Cardiologists, Ent Specialists, Homecare Nurses, Sleep Physicians, Pulse Oximeters)
• Therapeutic Devices (Positive Airway Pressure (Pap) Devices, Cpap, Apap, Bi-Pap, Oral Devices, Nasal Devices, Chin Straps)
• Sleep Apnea Masks

By End Use

• Hospitals And Sleep Labs
• Home Care

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oral Sleep Apnea Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Sleep Apnea Devices market include Vendor Landscape, Respironics (a subsidiary of Koninklijke Philips N.V.), Fisher & Paykel Healthcare Limited, Curative Medical, Inc., React Health (Respiratory Product Line from Invacare Corporation), Somnetics International, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, SOMNOmedics GmbH, Compumedics, Itamar Medical Ltd., Nihon Kohden Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORAL SLEEP APNEA DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By End Use
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORAL SLEEP APNEA DEVICES MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Diagnostic Devices (Actigraphs, Polysomnography (PSG) Device, Respiratory Polygraphs, Cardiologists, ENT Specialists, Homecare Nurses, Sleep Physicians, Pulse Oximeters) Historic and Forecast Sales by Regions
• 5.5 Therapeutic Devices (Positive Airway Pressure (PAP) Devices, CPAP, APAP, Bi-PAP, Oral Devices, Nasal Devices, Chin Straps) Historic and Forecast Sales by Regions
• 5.6 Sleep Apnea Masks Historic and Forecast Sales by Regions

6 . GLOBAL ORAL SLEEP APNEA DEVICES MARKET ANALYSIS BY END USE

• 6.1 Overview by End Use
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End Use
• 6.4 Hospitals and Sleep Labs Historic and Forecast Sales by Regions
• 6.5 Home Care Historic and Forecast Sales by Regions

7 . GLOBAL ORAL SLEEP APNEA DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ORAL SLEEP APNEA DEVICES COMPANIES

• 8.1. Oral Sleep Apnea Devices Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF ORAL SLEEP APNEA DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Vendor Landscape
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Respironics (a subsidiary of Koninklijke Philips N.V.)
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Fisher & Paykel Healthcare Limited
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Curative Medical Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. React Health (Respiratory Product Line from Invacare Corporation)
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Somnetics International Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. BMC Medical Co. Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Natus Medical Incorporated
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. SOMNOmedics GmbH
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Compumedics
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. Itamar Medical Ltd.
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Nihon Kohden Corporation
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies